Repository logo
Log In(current)
  • Inicio
  • Personal de Investigación
  • Unidad Académica
  • Publicaciones
  • Colecciones
    Datos de Investigacion Divulgacion cientifica Personal de Investigacion Protecciones Proyectos Externos Proyectos Internos Publicaciones Tesis
  1. Home
  2. Universidad de Santiago de Chile
  3. Publicaciones ANID
  4. Lithraea Caustic (Litre) Extract Promotes an Antitumor Response Against b16 Melanoma
Details

Lithraea Caustic (Litre) Extract Promotes an Antitumor Response Against b16 Melanoma

Journal
Frontiers in Pharmacology
ISSN
1663-9812
Date Issued
2019
Author(s)
Rojas-Pavez, J  
Imarai-Bahamonde, C  
Acuna-Castillo, C  
Leiva-Salcedo, D  
Santander-Meyer, R  
Robles-Planells, C  
Rojo-Castillo, L  
Mena-Silva, J  
Barrera-Ávalos, C  
Michelson-Quintana, S  
DOI
https://doi.org/10.3389/fphar.2019.01201
Abstract
Melanoma immunotherapy, specifically the autotransplant of dendritic cells charged with tumors antigens, has shown promising results in clinical trials. The positive clinical effects of this therapy have been associated to increased Th17 response and delayed-type hypersensitivity (DTH) against to tumor antigens. Some synthetic compounds, such as diphenylcyclopropenone (DPCP), are capable of triggering a DTH response in cutaneous malignancies and also to induce clinically relevant effects against melanoma. In this work, we evaluated Litre extract (LExT), a standardized extract of a Chilean stinging plant, Lithraea caustic (Litre). As Litre plant is known to induce DTH, we used a murine B16 melanoma model to compare the topical and intratumor efficacy of LExT with synthetic DTH inducers (DPCP and 2,4-dinitrochlorobenzene [DNCB]). LExt contained mainly long chain catechols and sesquiterpenes. The intratumor injection of LExT induced a significant delay in tumor growth, similarly topical treatment of an established tumor with 0.1% LExT ointment induced a growth delay and even tumor regression in 15% of treated animals. No significant changes were observed on the T-cell populations associated to LExT treatment, and neither DNCB nor DPCP were capable to induce none of the LExT-induced antitumoral effects. Interestingly, our results indicate that LExT induces an antitumor response against melanoma in a mouse model and could bring a new -and affordable- treatment for melanoma in humans. © 2019 Robles-Planells, Michelson, Mena, Escrig, Rojas, Sanchez-Guerrero, Hernández, Barrera-Avalos, Rojo, Sauma, Kalergis, Imarai, Fernández, Robles, Leiva-Salcedo, Santander, Escobar and Acuña-Castillo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Logo USACH

Universidad de Santiago de Chile
Avenida Libertador Bernardo O'Higgins nº 3363. Estación Central. Santiago Chile.
ciencia.abierta@usach.cl © 2023
The DSpace CRIS Project - Modificado por VRIIC USACH.

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Logo DSpace-CRIS
Repository logo COAR Notify